Novo Nordisk has raised its offer to buy out obesity biotech Metsera to $10bn as a bidding war with Pfizer intensifies. This is up from the $8.5bn that …
Tag:
Novo Nordisk has raised its offer to buy out obesity biotech Metsera to $10bn as a bidding war with Pfizer intensifies. This is up from the $8.5bn that …
At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.